This inventor holds 1 USPTO granted patent. Top assignee: National Research Council of Canada. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Darin Bloemberg: Innovator in Antigen-Binding Agents
Introduction
Darin Bloemberg is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of biomedical research, particularly in the development of antigen-binding agents. His work focuses on addressing critical challenges in cancer treatment and diagnostics.
Latest Patents
Darin holds a patent for "Antigen-Binding Agents That Specifically Bind Epidermal Growth Factor Receptor Variant III." This innovative patent highlights his expertise in creating targeted therapies that can potentially improve patient outcomes in oncology.
Career Highlights
Darin is affiliated with the National Research Council of Canada, where he conducts research that bridges the gap between scientific discovery and practical application. His dedication to advancing medical science is evident in his work and the impact it has on the healthcare community.
Collaborations
Darin has collaborated with esteemed colleagues such as Scott Mccomb and Risini Dhammika Weeratna. These partnerships enhance the research environment and foster innovation in their respective fields.
Conclusion
Darin Bloemberg's contributions to the field of antigen-binding agents exemplify the importance of innovation in medical research. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.